Hubei Biocause Heilen Pharmaceutical Co., Ltd.

¥10.89As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301211Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (11.83%)
Div yield 0.55%
ROE 2.36%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.61
PE TTM 91.95
TSR TTM (19.59%)
Mkt cap ¥4.548B
ROIC 1.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
1.49%
(46.83%)
Hold 12|3|6|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.15
0.16
22.51%
15.56%
2.27%
9.49%
Revenue¥M
263.5
266.9
268.5
277.9
8.02%
7.08%
10.40%
9.93%
Peers (US$681.7M)
Cap (US$)
PE
690.6M
69.13x
686.4M
16.18x
677.9M
13.74x
684.0M
48.73x
Capital
TTM
5Y
10Y
Leveragex
1.410
0.078
0.070
EBIT/Intx
1.077
0.203
0.207
Own earn%
277.05
(8.96)
(0.23)
Sh yield%
44.68
28.93
29.40
Owners
Insiders/Inst%
9.74
38.09
Short interest%
5.25
SBC / revenue%
5.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
25–30
$1 testx
0.2
Incr. ROIC%
6